A “Game Changer” For The High-Risk MDS Patient Population
Citeline Podcasts - Een podcast door Citeline
Categorieën:
Juho Jalkanen, CEO of Faron Pharma, discusses the importance of addressing unmet medical needs in cancer through breaking treatment resistance and developing long-term solutions. In Vivo questions the current progress of their lead asset BEXMAB and its potential moving forward.
